A new ICD-system with fractally coated single lead;Ein neues ICD-system mit fraktal beschichteter mono-sonde (Phylax 06): Implantationsdaten und klinische erfahrungen der ersten zwei jahre

Herz Kreislauf

Volumn 31, Issue 5, 1999, Pages 173-177

  Redling, F ^a,c   Bushnaq, H ^a   Hofmann, H S ^b   Hoh, G ^a   Zerkowski, H R ^c  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b DESSAU MEDICAL CENTER   (Germany)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Charging time; Defibrillation threshold; Implantable cardioverter defibrillator; Transvenous leads

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BIOMEDICAL ENGINEERING; CARDIOMYOPATHY; CHILD; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEFIBRILLATION; DEFIBRILLATOR; ELECTRODE; FEMALE; HEART PACING; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPEDANCE; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALE; SCHOOL CHILD;

EID: 0032903956     PISSN: 00467324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. The AntiArrhythmics versus Implantable Defibrillators [AVID] Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engt J Med 1997; 337: 1576-83.
2. Bolz A, Bieberle T, Schaldach M. Fractal Electrodes for Improved Control of Implantable Def/bri/lators. Proc. of the 7th Internat. IMEKO TC-13 Conference on Measurement in Clinical Medicine: Model Based Biomeasurements 1995: 109-11.
3. Grimm W, Menz V, Hoffmann J, et al.. Klinische Erfahrungen mit implantierbaren Kardioverter-Defibrillatoren der 3. Generation. Herz/Kreist 1998; 30: 197-205.
4. Jones JL Ventricular Fibrillation. In: Singer l, ed. Implantable Card/overter Defibr/l/ator. Armonk, NY: futura Publishing Company 1994: 43-67.
5. Kennergren C. Impact of Imp/ant Techniques on Complications with current Implantable Cardioverter-Defibrillator Systems. Am J Cardiol 1996; 78: 15-20.
6. Klein H, Auricchio A, Huvelle E, Nisam S. Initial Experience with a New Down-Sized Implantable Cardioverter-Defibri/lator. Am J Cardiol 1996; 78: 9-14.
7. MADIT Executive Committee. Mult/center Automatic Defibn/lator Implantation Trial (MADIT). Design and Clinical Protocol. PACE 1991; H: 920-7.
8. Moss AJ, Hall WJ, Cannom DS, et al.. Improved Survival with an Implantable Defibrillator in Patients with Coronary Disease at High Risk of Ventricular Arrhythmias. N EngU Med 1996; 335: 1933-40.
9. Mower MM. Automatic implantab/e cardioverterdefibrillator: History and future developments. ZKardiol 1995; 84 (Suppl. 2): 123-6.
10. Neuzner J. Safety Margins: Lessons from the Low Energy Endotak Trial (LEET). Am J Cardiol 1996; 78:26-32.
11. Pfeiffer D, Jung W, Fehske W, Körte T, Manz M, Moosdorf R, Lüderitz B. Complications of pacemaker-defibrillator devices: diagnosis and management. Am Heart J 1994; 127: 1073-80.
12. Schuder JC. The Role of an Engineering Oriented Medical Research Group in Developing Improved Methods and Devices for Achieving Ventricular Defibn/lation: The University of Missouri Experience. PACE 1993; 16:95-124.
13. Trappe HJ. Defibrillator-Therapie 1997. Voraussetzungen - Ergebnisse - Perspektiven. Med Klin 1997:92:415-20.
14. Trappe HJ. The modern imp/antable cardioverterdefibrillator: comparing it to those of the late 1980s. Am J Cardiol 1996; 78: 3-8.
15. Trappe HJ, Pfitzner P. Häufigkeit von inadäquaten Therapien. In: Wiethold D, Ulbricht U, Gülker H, Hrsg. Implantierbare Kardioverter-Defibri/latoren. Stuttgart-New York: Thieme 1997: 137-46.
16. Wiethold D. Mortalität. In: Wietho/d D, U/bricht U, Gülker H, Hrsg. Implantierbare Kardioverter-Defibrillatoren. Stuttgart-New York: Thieme 1997: 91-4.
17. Wiethold D. Morbidität. In: Wiethold D, Ulbricht LJ, Gülker H, Hrsg. Implantierbare Kardioverter-Defibrillatoren. Stuttgart-New York: Thieme 1997: 95-101.
18. Winkle RA, Mead RH, Ruder MA, et al.. Longterm Outcome with the Automatic Implantable Cardioverter Defibrillator. JACC 1989; 13: 1353-61.